RU2662668C2 - Способ непрерывной многостадийной очистки антител - Google Patents

Способ непрерывной многостадийной очистки антител Download PDF

Info

Publication number
RU2662668C2
RU2662668C2 RU2015151869A RU2015151869A RU2662668C2 RU 2662668 C2 RU2662668 C2 RU 2662668C2 RU 2015151869 A RU2015151869 A RU 2015151869A RU 2015151869 A RU2015151869 A RU 2015151869A RU 2662668 C2 RU2662668 C2 RU 2662668C2
Authority
RU
Russia
Prior art keywords
chromatographic
protein
buffer
passing
chromatographic column
Prior art date
Application number
RU2015151869A
Other languages
English (en)
Russian (ru)
Other versions
RU2015151869A (ru
Inventor
Дидье ДЮТ
Селин ЭМЕ
Лор ЛАНДРИК-БЮРТЕН
Бенуа МОТ
Original Assignee
Санофи
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Санофи filed Critical Санофи
Publication of RU2015151869A publication Critical patent/RU2015151869A/ru
Application granted granted Critical
Publication of RU2662668C2 publication Critical patent/RU2662668C2/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/12—Purification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Sustainable Development (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Water Supply & Treatment (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
RU2015151869A 2013-05-06 2014-05-06 Способ непрерывной многостадийной очистки антител RU2662668C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13305593 2013-05-06
EP13305593.9 2013-05-06
PCT/EP2014/059246 WO2014180852A1 (en) 2013-05-06 2014-05-06 Continuous multistep process for purifying antibodies

Publications (2)

Publication Number Publication Date
RU2015151869A RU2015151869A (ru) 2017-06-13
RU2662668C2 true RU2662668C2 (ru) 2018-07-26

Family

ID=48430636

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2015151869A RU2662668C2 (ru) 2013-05-06 2014-05-06 Способ непрерывной многостадийной очистки антител

Country Status (19)

Country Link
US (1) US10793622B2 (enExample)
EP (2) EP3301115B1 (enExample)
JP (2) JP6463734B2 (enExample)
KR (1) KR102272851B1 (enExample)
CN (2) CN116003579A (enExample)
AU (1) AU2014264697B2 (enExample)
BR (1) BR112015027812B1 (enExample)
CA (1) CA2911462C (enExample)
CY (1) CY1125281T1 (enExample)
DK (2) DK2994485T3 (enExample)
ES (2) ES2665645T3 (enExample)
HU (2) HUE038741T2 (enExample)
IL (1) IL242408B (enExample)
MX (1) MX368177B (enExample)
NO (1) NO2994485T3 (enExample)
RU (1) RU2662668C2 (enExample)
SG (1) SG11201508968XA (enExample)
TW (2) TWI631132B (enExample)
WO (1) WO2014180852A1 (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9458450B2 (en) 2012-03-15 2016-10-04 Flodesign Sonics, Inc. Acoustophoretic separation technology using multi-dimensional standing waves
US10704021B2 (en) 2012-03-15 2020-07-07 Flodesign Sonics, Inc. Acoustic perfusion devices
US10967298B2 (en) 2012-03-15 2021-04-06 Flodesign Sonics, Inc. Driver and control for variable impedence load
US9950282B2 (en) 2012-03-15 2018-04-24 Flodesign Sonics, Inc. Electronic configuration and control for acoustic standing wave generation
MX379269B (es) * 2012-10-24 2025-03-11 Genzyme Corp Elucion de biomoleculas de resinas multimodales utilizando mes y mops como modificadores de fase movil.
KR20160054597A (ko) * 2013-09-17 2016-05-16 가부시키가이샤 가네카 신규 항체 정제 방법 및 그로부터 얻어지는 항체, 및 양이온 교환기를 사용한 신규 항체 정제법 및 그로부터 얻어지는 항체
CN105939767B (zh) 2014-01-08 2018-04-06 弗洛设计声能学公司 具有双声电泳腔的声电泳装置
GB201503578D0 (en) * 2015-03-03 2015-04-15 Ge Healthcare Bio Sciences Ab Sanitization method for affinity chromatography matrices
US11021699B2 (en) 2015-04-29 2021-06-01 FioDesign Sonics, Inc. Separation using angled acoustic waves
US11708572B2 (en) 2015-04-29 2023-07-25 Flodesign Sonics, Inc. Acoustic cell separation techniques and processes
US11377651B2 (en) 2016-10-19 2022-07-05 Flodesign Sonics, Inc. Cell therapy processes utilizing acoustophoresis
EP3015542A1 (de) * 2015-05-07 2016-05-04 Bayer Technology Services GmbH Modulare anlage und verfahren zur kontinuierlichen, keimreduzierten produktion und/oder aufbereitung eines produktes
US11474085B2 (en) 2015-07-28 2022-10-18 Flodesign Sonics, Inc. Expanded bed affinity selection
US11459540B2 (en) 2015-07-28 2022-10-04 Flodesign Sonics, Inc. Expanded bed affinity selection
US20170101437A1 (en) * 2015-10-09 2017-04-13 Hetero Drugs Ltd. Process for purification of darbepoetin alfa
US11214789B2 (en) 2016-05-03 2022-01-04 Flodesign Sonics, Inc. Concentration and washing of particles with acoustics
US11085035B2 (en) 2016-05-03 2021-08-10 Flodesign Sonics, Inc. Therapeutic cell washing, concentration, and separation utilizing acoustophoresis
WO2018051348A1 (en) * 2016-09-14 2018-03-22 Insight Biopharmaceutical Ltd. Methods of purifying and qualifying antibodies
EP3529347A1 (en) 2016-10-19 2019-08-28 Flodesign Sonics, Inc. Affinity cell extraction by acoustics
MX2019011343A (es) * 2017-03-24 2019-11-18 Council Scient Ind Res Un procedimiento para la purificacion de fragmentos de anticuerpos recombinantes.
GB201711481D0 (en) * 2017-07-17 2017-08-30 Ucb Biopharma Sprl Protein purification
CN111065735B (zh) * 2017-08-31 2023-07-07 株式会社绿十字 用于纯化硫酸酯酶蛋白的方法
CN114900773A (zh) 2017-12-14 2022-08-12 弗洛设计声能学公司 声泳系统及其操作方法、控制声换能器及声学系统的方法
US11155575B2 (en) 2018-03-21 2021-10-26 Waters Technologies Corporation Non-antibody high-affinity-based sample preparation, sorbent, devices and methods
EP3546475A1 (en) 2018-03-27 2019-10-02 Sanofi Full flow-through process for purifying recombinant proteins
US12071607B2 (en) * 2018-06-01 2024-08-27 Lonza Ltd. Midscale model for organic growth and phasing
KR102337683B1 (ko) * 2018-09-21 2021-12-13 주식회사 녹십자 고효율 항-tfpi 항체 조성물
EP3636657A1 (en) 2018-10-08 2020-04-15 Ablynx N.V. Chromatography-free antibody purification method
WO2020084503A1 (en) * 2018-10-26 2020-04-30 Cadila Healthcare Limited A composition comprising antibody with reduced level of basic variants thereof
WO2020183332A1 (en) * 2019-03-11 2020-09-17 Intas Pharmaceuticals Ltd. Purification of adalimumab using tandem chromatography
CN113825840A (zh) * 2019-04-03 2021-12-21 建新公司 重组蛋白的连续生产
CN114026108B (zh) * 2019-06-28 2024-09-10 夏尔巴生物技术(苏州)有限公司 无缝连续流层析方法
CA3154726A1 (en) * 2019-09-23 2021-04-01 Merck Sharp & Dohme Corp. Methods and compositions comprising an anti-ctla4 monoclonal antibody with reduced host cell proteins and increased polysorbate-80 stability
KR102154952B1 (ko) * 2020-02-21 2020-09-10 프레스티지바이오로직스 주식회사 아달리무맙의 Non-Protein A 정제방법
CN112574321B (zh) * 2020-12-30 2023-10-20 上海赛金生物医药有限公司 一种捕获单克隆抗体-肿瘤坏死因子融合蛋白的亲和纯化方法
WO2022234412A1 (en) 2021-05-03 2022-11-10 Lupin Limited A process for purification of fc-fusion proteins

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2145873C1 (ru) * 1993-09-21 2000-02-27 Хемосол Инк. Способ очистки гемоглобина в коммерческом масштабе

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE121418T1 (de) 1987-10-23 1995-05-15 Schering Corp Verfahren zur proteinreinigung.
CA2106612C (en) 1993-09-21 2001-02-06 Diana Pliura Displacement chromatography process
US5891741A (en) 1997-05-16 1999-04-06 Coulter International Corp. Antibody-aminodextran-phycobiliprotein conjugates
CN1136317C (zh) 1999-03-12 2004-01-28 中国人民解放军第四军医大学 单克隆抗体双段和单段的制备方法
US20020009445A1 (en) 2000-07-12 2002-01-24 Yansheng Du Human beta-amyloid antibody and use thereof for treatment of alzheimer's disease
US6602855B2 (en) 2001-04-30 2003-08-05 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1449 daltons
CN1504482A (zh) * 2002-12-03 2004-06-16 北京优力凯生物技术有限责任公司 无细胞百日咳抗原蛋白的分离纯化方法
PL1745075T3 (pl) 2004-04-21 2013-09-30 Brigham & Womens Hospital Inc Peptydy wiążące poli-N-acetyloglukozaminę (PNAG/DPNAG) i sposoby ich zastosowania
KR101243425B1 (ko) * 2004-10-21 2013-03-13 지이 헬스케어 바이오-사이언시스 에이비 항체의 정제 방법
EP2551282A3 (en) 2005-03-23 2013-02-13 Genmab A/S Antibodies against CD38 for treatment of multiple myeloma
CN1814775A (zh) 2005-12-06 2006-08-09 中国海洋大学 一种抗病毒活性寡聚肽的制备方法
EP1914242A1 (en) * 2006-10-19 2008-04-23 Sanofi-Aventis Novel anti-CD38 antibodies for the treatment of cancer
BRPI0814220B8 (pt) 2007-07-11 2021-05-25 Novo Nordisk As purificação de fator viii usando uma resina multimodal ou de modo misto
AU2008322523B2 (en) 2007-11-16 2013-10-10 The Rockefeller University Antibodies specific for the protofibril form of beta-amyloid protein
TWI472339B (zh) * 2008-01-30 2015-02-11 Genentech Inc 包含結合至ｈｅｒ２結構域ii之抗體及其酸性變異體的組合物
JP2011514895A (ja) * 2008-02-29 2011-05-12 バイオジェン・アイデック・エムエイ・インコーポレイテッド 精製免疫グロブリン融合タンパク質およびその精製方法
CN103396480A (zh) * 2008-05-15 2013-11-20 诺沃—诺迪斯克有限公司 抗体纯化方法
NZ590257A (en) * 2008-07-18 2012-08-31 Grifols Therapeutics Inc Method of preparing alpha-1 proteinase inhibitor
WO2010071208A1 (ja) 2008-12-19 2010-06-24 武田薬品工業株式会社 抗体の精製方法
CN102272146A (zh) 2009-01-13 2011-12-07 通用电气健康护理生物科学股份公司 用带负电的聚合物沉淀生物分子
KR101224468B1 (ko) * 2009-05-20 2013-01-23 주식회사 파멥신 신규한 형태의 이중표적항체 및 그 용도
US8536316B2 (en) * 2009-08-07 2013-09-17 Emd Millipore Corporation Methods for purifying a target protein from one or more impurities in a sample
BR112012004697B8 (pt) * 2009-09-01 2021-05-25 Genentech Inc método para purificar um polipeptídeo compreendendo uma região ch2/ch3
US9527010B2 (en) * 2009-09-25 2016-12-27 Ge Healthcare Bio-Sciences Corp. Separation system and method
WO2011049798A1 (en) * 2009-10-20 2011-04-28 Merck Sharp & Dohme Corp. Use of mixed mode chromatography for the capture and purification of basic antibody products
WO2011090719A2 (en) 2009-12-29 2011-07-28 Dr. Reddy's Laboratories Ltd. Protein purification by ion exchange
ES2534936T3 (es) 2010-08-02 2015-04-30 Ratiopharm Gmbh Método para producir y purificar una sialiltransferasa soluble activa
US20120238730A1 (en) * 2011-03-15 2012-09-20 Abbott Laboratories Integrated approach to the isolation and purification of antibodies
EP2691411B1 (en) * 2011-03-29 2020-02-26 GlaxoSmithKline LLC Buffer system for protein purification
WO2012174535A1 (en) 2011-06-17 2012-12-20 Constitution Medical, Inc. Solutions for histoprocessing of biological samples
US9096648B2 (en) 2011-08-19 2015-08-04 Emd Millipore Corporation Methods of reducing level of one or more impurities in a sample during protein purification
EP2578286A1 (en) * 2011-10-04 2013-04-10 Merck Patent GmbH Method and apparatus for chromatographic purification
BR112014009866A2 (pt) * 2011-10-25 2018-09-04 Onclave Therapeutics Limited formulações de anticorpos e métodos
WO2013075740A1 (en) 2011-11-23 2013-05-30 Sanofi Antibody purification method

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2145873C1 (ru) * 1993-09-21 2000-02-27 Хемосол Инк. Способ очистки гемоглобина в коммерческом масштабе

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Follman D. K., Fahrner R. L. Factorial screening of antibody purification processes using three chromatography steps without protein A. Journal of chromatography A. - 2004. - Vol. 1024. - n. 1. - P. 79-85. *
Mahajan E., George A., Wolk B. Improving affinity chromatography resin efficiency using semi-continuous chromatography. Journal of chromatography A. - 2012. - Vol. 1227. - P. 154-162. *
Mahajan E., George A., Wolk B. Improving affinity chromatography resin efficiency using semi-continuous chromatography. Journal of chromatography A. - 2012. - Vol. 1227. - P. 154-162. Pollock J. et al. Optimising the design and operation of semi-continuous affinity chromatography for clinical and commercial manufacture. Journal of Chromatography A. - 2013. - Vol. 1284. - P. 17-27. Follman D. K., Fahrner R. L. Factorial screening of antibody purification processes using three chromatography steps without protein A. Journal of chromatography A. - 2004. - Vol. 1024. - n. 1. - P. 79-85. *
Pollock J. et al. Optimising the design and operation of semi-continuous affinity chromatography for clinical and commercial manufacture. Journal of Chromatography A. - 2013. - Vol. 1284. - P. 17-27. *

Also Published As

Publication number Publication date
TWI631132B (zh) 2018-08-01
NO2994485T3 (enExample) 2018-06-09
EP2994485A1 (en) 2016-03-16
EP3301115B1 (en) 2021-11-10
CN116003579A (zh) 2023-04-25
ES2905675T3 (es) 2022-04-11
CN105358572A (zh) 2016-02-24
JP2019104735A (ja) 2019-06-27
AU2014264697A1 (en) 2015-11-26
KR20160005047A (ko) 2016-01-13
CA2911462C (en) 2021-04-06
KR102272851B1 (ko) 2021-07-02
RU2015151869A (ru) 2017-06-13
BR112015027812A2 (pt) 2017-07-25
TWI675041B (zh) 2019-10-21
TW201908331A (zh) 2019-03-01
JP6463734B2 (ja) 2019-02-06
MX2015015482A (es) 2016-03-21
TW201522363A (zh) 2015-06-16
ES2665645T3 (es) 2018-04-26
JP2016519137A (ja) 2016-06-30
BR112015027812B1 (pt) 2021-03-30
CY1125281T1 (el) 2023-06-09
US10793622B2 (en) 2020-10-06
HUE057119T2 (hu) 2022-04-28
MX368177B (es) 2019-09-23
HUE038741T2 (hu) 2018-11-28
IL242408B (en) 2020-04-30
EP2994485B1 (en) 2018-01-10
DK3301115T3 (da) 2022-01-31
AU2014264697B2 (en) 2019-08-22
DK2994485T3 (en) 2018-04-23
SG11201508968XA (en) 2015-11-27
EP3301115A1 (en) 2018-04-04
US20160083454A1 (en) 2016-03-24
CA2911462A1 (en) 2014-11-13
WO2014180852A1 (en) 2014-11-13

Similar Documents

Publication Publication Date Title
JP6463734B2 (ja) 抗体を精製するための連続的多工程法
TWI671312B (zh) 無菌層析法及製法
US10071364B2 (en) Sterile affinity chromatography resin
US12391728B2 (en) Full flow-through process for purifying recombinant proteins
JP7635213B2 (ja) クロマトグラフィーの使用および再生のためのシステムおよび方法
HK40091913A (en) Continuous multistep process for purifying antibodies